TRANSGENE (EPA:TNG) | WebDisclosure

PRESS RELEASE

published on 09/14/2024 at 09:05, 2 years ago

Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments
Transgene and BioInvent present promising early results of oncolytic virus BT-001 in ESMO 2024, showing antitumor activity in solid tumors. BT-001 induces tumor regression and enhances T cell infiltration

Transgene Oncolytic Virus BioInvent Antitumor Activity ESMO 2024
BRIEF

published on 09/13/2024 at 10:37, 2 years ago

Franchissement de seuil par SITAM Belgique dans TRANSGENE S.A.

Droits De Vote Franchissement De Seuil Augmentation De Capital SITAM Belgique TRANSGENE S.A.
BRIEF

published on 09/13/2024 at 10:37, 2 years ago

Threshold crossing by SITAM Belgium in TRANSGENE SA

Voting Rights Capital Increase Threshold Crossing SITAM Belgium TRANSGENE SA
PRESS RELEASE

published on 09/13/2024 at 10:32, 2 years ago

Franchissement de seuil
Déclaration de franchissement de seuil de la société TRANSGENE S.A. par SITAM Belgique, détenant 3,65% du capital et 4,85% des droits de vote

Déclaration Franchissement De Seuil AMF SITAM Belgique TRANSGENE S.A.
BRIEF

published on 09/10/2024 at 07:35, 2 years ago

Transgene Appoints Two Seasoned Leaders in Oncology to Drive its Next Phase of Innovation

Cancer Treatment Oncology Leadership Immunotherapy Transgene
BRIEF

published on 09/10/2024 at 07:35, 2 years ago

Transgene nomme deux leaders chevronnés en oncologie pour piloter sa prochaine phase d'innovation

Immunothérapie Direction Oncologie Traitement Du Cancer Transgene
PRESS RELEASE

published on 09/10/2024 at 07:30, 2 years ago

Transgene Appoints Two Seasoned Leaders in Oncology to Drive its Next Phase of Innovation
Transgene appoints Dr. Emmanuelle Dochy as CMO and Dr. Maurizio Ceppi as CSO to drive innovation in cancer immunotherapies. Company progresses clinical pipeline with therapeutic vaccine TG4050

Innovation Oncology Clinical Pipeline Immunotherapy Transgene
BRIEF

published on 08/27/2024 at 07:35, 2 years 1 month ago

Transgene Publishes Preclinical Data on Oncolytic Virus TG6050 in JITC

Preclinical Data Transgene Oncolytic Virus TG6050 JITC
BRIEF

published on 08/27/2024 at 07:35, 2 years 1 month ago

Transgene publie des données précliniques sur le virus oncolytique TG6050 au JITC

Transgene Données Précliniques TG6050 JITC Virus Oncolytique
PRESS RELEASE

published on 08/27/2024 at 07:30, 2 years 1 month ago

Transgene — Preclinical Proof-of-Concept Data of Oncolytic Virus TG6050 published in JITC
Transgene announces preclinical proof-of-concept data of oncolytic virus TG6050 published in JITC, showcasing tumor regression and immune remodeling capabilities without systemic toxicity. TG6050 progressing in Phase I trial for NSCLC

Phase I Trial Transgene Oncolytic Virus TG6050 JITC Publication

Published on 09/28/2026 at 10:00, 31 minutes ago

Eagle Plains' Partner Xcite Uranium Intersects Anomalous Radioactivity at Lorado and Commences Drill Program at the Gulch Uranium Project, Saskatchewan
Published on 09/28/2026 at 08:00, 2 hours 31 minutes ago

Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Published on 09/26/2026 at 01:00, 2 days 9 hours ago

Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 2 days 9 hours ago

Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 2 days 12 hours ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

Published on 09/28/2026 at 10:15, 15 minutes ago

EQS-Adhoc: AGRANA Beteiligungs-Aktiengesellschaft: AGRANA raises EBIT forecast for 2026|27 financial year
Published on 09/28/2026 at 10:15, 16 minutes ago

EcoGraf HFfree® South Korea Patent Granted
Published on 09/28/2026 at 10:05, 26 minutes ago

SON Estrella Galicia Posidonia celebrates its 10th anniversary with a decade of music, culture and unique experiences in Formentera
Published on 09/28/2026 at 10:00, 31 minutes ago

Original-Research: MustGrow Biologics Corp. (von GBC AG): Buy
Published on 09/28/2026 at 09:29, 1 hour 2 minutes ago

Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Add

View all EQS

Published on 09/28/2026 at 08:45, 1 hour 46 minutes ago

BAIKOWSKI: 2026 first-half results
Published on 09/28/2026 at 08:45, 1 hour 46 minutes ago

BAIKOWSKI : Résultats du 1er semestre 2026
Published on 09/28/2026 at 08:02, 2 hours 29 minutes ago

Saint-Gobain signs renewable electricity purchase agreement in the United Kingdom
Published on 09/28/2026 at 08:02, 2 hours 29 minutes ago

Saint-Gobain signe un contrat d’achat d’électricité renouvelable au Royaume-Uni
Published on 09/28/2026 at 07:45, 2 hours 46 minutes ago

BAIKOWSKI : Rapport financier semestriel 2026

View all LES ECHOS COMFI WIRE

News